When Philadelphia-based mental health tech company NeuroFlow raised an early-stage round of $1.5 million two years ago, one of its customers, an independent psychologist in the city who used its software with his patients liked the product so much he decided to invest and cut the company a check.
More than two years later, that same dynamic is playing out — but on a much larger scale.
This time, Phoenix-based Fortune 500 managed health care company Magellan Health led a $20 million Series…
Leave a Reply